Loss of the ability to walk often occurs by 12 years of age and development of cardiomyopathy is typically seen around 14 years of age
With these data, it is apparent the role GLP-1 and GLP-1/GIP medications will play in the future, necessitating a proper understanding of their side effect profile and complications that may arise
Your weight loss depends on several factors, including: Lifestyle habits Dose Starting weight Overall health To experience consistent progress, its best to pair weight loss drugs (e.g., semaglutide, tirzepatide) with dietary changes, physical activity, and regular medical supervision
Best for: Biomarker tracking, early disease detection, and performance optimization
Our dedicated healthcare providers will closely evaluate your unique health profile and goals, offering personalized services and support every step of the way
There doesnt appear to be an appetite for expanded coverage